PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.99%
Revenue decline while 3088.T shows 4.69% growth. Joel Greenblatt would examine competitive position erosion.
-4.18%
Cost reduction while 3088.T shows 2.90% growth. Joel Greenblatt would examine competitive advantage.
-3.25%
Gross profit decline while 3088.T shows 8.20% growth. Joel Greenblatt would examine competitive position.
0.78%
Margin expansion below 50% of 3088.T's 3.35%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.68%
Other expenses growth above 1.5x 3088.T's 3.64%. Michael Burry would check for concerning trends.
3.12%
Operating expenses growth 50-75% of 3088.T's 4.18%. Bruce Berkowitz would examine efficiency.
-2.95%
Total costs reduction while 3088.T shows 3.29% growth. Joel Greenblatt would examine advantage.
-8.33%
Interest expense reduction while 3088.T shows 40.00% growth. Joel Greenblatt would examine advantage.
5.51%
D&A growth 1.25-1.5x 3088.T's 3.84%. Martin Whitman would scrutinize asset base.
-15.99%
EBITDA decline while 3088.T shows 19.73% growth. Joel Greenblatt would examine position.
-12.50%
EBITDA margin decline while 3088.T shows 14.37% growth. Joel Greenblatt would examine position.
-27.13%
Operating income decline while 3088.T shows 29.14% growth. Joel Greenblatt would examine position.
-24.11%
Operating margin decline while 3088.T shows 23.36% growth. Joel Greenblatt would examine position.
2.50%
Other expenses growth while 3088.T reduces costs. John Neff would investigate differences.
-25.03%
Pre-tax income decline while 3088.T shows 25.70% growth. Joel Greenblatt would examine position.
-21.91%
Pre-tax margin decline while 3088.T shows 20.06% growth. Joel Greenblatt would examine position.
-23.65%
Tax expense reduction while 3088.T shows 14.68% growth. Joel Greenblatt would examine advantage.
-25.66%
Net income decline while 3088.T shows 33.34% growth. Joel Greenblatt would examine position.
-22.57%
Net margin decline while 3088.T shows 27.37% growth. Joel Greenblatt would examine position.
-25.65%
EPS decline while 3088.T shows 300.91% growth. Joel Greenblatt would examine position.
-25.65%
Diluted EPS decline while 3088.T shows 300.80% growth. Joel Greenblatt would examine position.
-0.00%
Both companies reducing share counts. Martin Whitman would check patterns.
-0.00%
Both companies reducing diluted shares. Martin Whitman would check patterns.